ROBO1 and ovarian carcinoma: The experimental approach employed to generate ROBO1-NK cells and evaluate their anti-tumor efficacy against ROBO1-positive ovarian cancer cells is illustrated in Figure 1A. Initially, immunohistochemistry (IHC) analysis was performed to detect the presence of ROBO1 protein in ovarian cancer tumor tissues obtained from patients.